Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | INMD |
---|---|---|
09:32 ET | 9741 | 19.58 |
09:33 ET | 4722 | 19.54 |
09:35 ET | 7751 | 19.49 |
09:37 ET | 800 | 19.49 |
09:39 ET | 5260 | 19.475 |
09:42 ET | 2062 | 19.47 |
09:44 ET | 3639 | 19.465 |
09:46 ET | 3428 | 19.47 |
09:48 ET | 6421 | 19.44 |
09:50 ET | 10754 | 19.3906 |
09:51 ET | 2200 | 19.42 |
09:53 ET | 1908 | 19.42 |
09:55 ET | 871 | 19.41 |
09:57 ET | 5829 | 19.3724 |
10:00 ET | 640 | 19.37 |
10:02 ET | 10642 | 19.365 |
10:04 ET | 3008 | 19.38 |
10:06 ET | 1500 | 19.445 |
10:08 ET | 5300 | 19.45 |
10:09 ET | 3507 | 19.46 |
10:11 ET | 381 | 19.45 |
10:13 ET | 1287 | 19.46 |
10:15 ET | 1935 | 19.465 |
10:18 ET | 6319 | 19.45 |
10:20 ET | 2196 | 19.49 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Inmode Ltd | 1.5B | 10.6x | +45.75% |
iRhythm Technologies Inc | 2.6B | -18.0x | --- |
Accuray Inc | 197.1M | -10.7x | --- |
TruBridge Inc | 252.7M | -4.4x | --- |
Cytek Biosciences Inc | 825.7M | -82.9x | --- |
LeMaitre Vascular Inc | 2.4B | 58.6x | +3.81% |
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.5B |
---|---|
Revenue (TTM) | $423.7M |
Shares Outstanding | 76.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.08 |
EPS | $1.85 |
Book Value | $9.38 |
P/E Ratio | 10.6x |
Price/Sales (TTM) | 3.5 |
Price/Cash Flow (TTM) | 9.5x |
Operating Margin | 32.07% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.